DDInter1878 DDInter1180
A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat asthma; HAY fever; urticaria; and rhinitis; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Tripelennamine {u} (Compound) resembles {v} (Compound) Dimetacrine
Tripelennamine {u} (Compound) resembles {v} (Compound) Chloropyramine
Tripelennamine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Brompheniramine
Tripelennamine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Doxylamine
Tripelennamine {u} may lead to a major life threatening interaction when taken with {v} Dextropropoxyphene
Tripelennamine {u} (Compound) binds {v} (Gene) HRH1
Tripelennamine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Hyaluronidase
Tripelennamine {u} may lead to a major life threatening interaction when taken with {v} Zonisamide
Tripelennamine {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Disopyramide
Tripelennamine {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Orphenadrine
Tripelennamine (Compound) resembles Dimetacrine (Compound)
Tripelennamine (Compound) resembles Chloropyramine (Compound)
Tripelennamine may cause a moderate interaction that could exacerbate diseases when taken with Brompheniramine
Tripelennamine may cause a moderate interaction that could exacerbate diseases when taken with Doxylamine
Tripelennamine may lead to a major life threatening interaction when taken with Dextropropoxyphene
Tripelennamine (Compound) binds HRH1 (Gene)
Tripelennamine may cause a minor interaction that can limit clinical effects when taken with Hyaluronidase
Tripelennamine may lead to a major life threatening interaction when taken with Zonisamide
Tripelennamine (Compound) resembles Disopyramide (Compound) and Tripelennamine may cause a moderate interaction that could exacerbate diseases when taken with Disopyramide
Tripelennamine (Compound) resembles Orphenadrine (Compound) and Tripelennamine may cause a moderate interaction that could exacerbate diseases when taken with Orphenadrine